Australia - English - Department of Health (Therapeutic Goods Administration)

premalife pty ltd t/a natural vitality australia - cyanocobalamin, quantity: 10 microgram; nicotinamide, quantity: 30 mg; pyridoxine hydrochloride, quantity: 12 mg (equivalent: pyridoxine, qty 9.87 mg); calcium pantothenate, quantity: 12 mg (equivalent: pantothenic acid, qty 10.99 mg); riboflavine, quantity: 10 mg; zinc amino acid chelate, quantity: 25 mg (equivalent: zinc, qty 5 mg); calcium amino acid chelate, quantity: 125 mg (equivalent: calcium, qty 25 mg); magnesium amino acid chelate, quantity: 225 mg (equivalent: magnesium, qty 45 mg); biotin, quant - tablet, film coated - excipient ingredients: povidone; magnesium stearate; calcium hydrogen phosphate dihydrate; crospovidone; hypromellose; macrogol 400; carnauba wax - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) multi vitamin and mineral supplement

Australia - English - Department of Health (Therapeutic Goods Administration)

premalife pty ltd t/a natural vitality australia - zinc sulfate monohydrate, quantity: 1.45 mg/g (equivalent: zinc, qty 529 microgram/g); magnesium phosphate pentahydrate, quantity: 95 mg/g (equivalent: magnesium, qty 19.625 mg/g); calcium ascorbate dihydrate, quantity: 100 mg/g; calcium phosphate, quantity: 50 mg/g (equivalent: calcium, qty 19.5 mg/g); hesperidin, quantity: 95 mg/g; ascorbic acid, quantity: 400 mg/g - powder, oral - excipient ingredients: glucose monohydrate; silicon dioxide; fructose; stevia rebaudiana; flavour - maintain/support immune system health ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve symptoms of common cold

Australia - English - Department of Health (Therapeutic Goods Administration)

premalife pty ltd t/a natural vitality australia - foeniculum vulgare, quantity: 40 mg (equivalent: foeniculum vulgare, qty 200 mg); peppermint oil, quantity: 4 mg (equivalent: menthol, qty 2.2 mg); carica papaya, quantity: 100 mg (equivalent: carica papaya, qty 1.5 g); activated charcoal, quantity: 250 mg; zingiber officinale, quantity: 44 mg (equivalent: zingiber officinale, qty 220 mg) - capsule, hard - excipient ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; maltodextrin; calcium hydrogen phosphate; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum - decrease/reduce/relieve flatulence/carminative ; decrease/reduce/relieve abdominal bloating/distention ; decrease/reduce/relieve symptoms of indigestion/dyspepsia

Australia - English - Department of Health (Therapeutic Goods Administration)

natural force ( aust) pty ltd - ascorbic acid,avena sativa,calcium pantothenate,nicotinamide,panax ginseng,pyridoxine hydrochloride,tribulus terrestris,zinc sulfate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).

Australia - English - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: hydrochloric acid; sodium citrate dihydrate; citric acid; sodium chloride; water for injections; sodium hydroxide; disodium edetate - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - isoprenaline hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - isoprenaline hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - isoprenaline hydrochloride, quantity: 1 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).

Australia - English - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - isoprenaline hydrochloride, quantity: 200 microgram - injection, solution - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid; sodium chloride; disodium edetate; sodium citrate dihydrate; citric acid - isoprenaline hydrochloride is indicated: for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,for serious episodes of heart block and adams-stokes attacks (except when caused by ventricular tachycardia or fibrillation). (see section 4.3 contraindications),for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (see section 4.3 contraindications.),for bronchospasm occurring during anaesthesia.,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (see section 4.4 special warnings and precautions for use).